Clinical Trials Browser

Not yet recruiting × Pancreatic Neoplasms × camrelizumab × Clear all

NCT06759090 2025-01-06

Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced Pancreatic Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms